治疗髓寡二细胞糖蛋白抗体相关疾病 (MOGAD) 的新兴原则
Andrew B Wolf1, Jacqueline Palace2,3, Jeffrey L Bennett1,4,5
1Department of Neurology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
髓寡细胞糖蛋白抗体相关疾病 (MOGAD) 是一种罕见的炎症性中枢神经系统疾病. 新的诊断标准和疗法,包括皮质类固醇和新兴治疗方法,对于管理MOGAD复发和改善患者护理至关重要.
科学领域:
- 神经免疫学 神经免疫学
- 中枢神经系统疾病 中枢神经系统疾病
背景情况:
- 髓寡干细胞糖蛋白抗体相关疾病 (MOGAD) 是一种罕见的炎症性中枢神经系统疾病,影响成人和儿童.
- 在MOGAD中神经障碍是复发驱动的,需要早期诊断和有针对性的治疗.
研究的目的:
- 审查MOGAD新确立的诊断标准.
- 检查对MOGAD急性和预防性治疗的现有证据.
主要方法:
- 国际MOGAD小组对MOGAD诊断的第一个临床,实验室和放射学标准的审查.
- 对MOGAD急性护理和预防的非标签药物的回顾性研究的评估.
- 考虑正在进行的潜在随机临床试验.
主要成果:
- 新的诊断标准为临床研究和未来的试验提供了基础.
- 急性MOGAD发作通常对高剂量的皮质类固醇有反应;血交换或IVIG可能有助于严重或耐火病例.
- 慢慢地减少皮质类固醇可以降低复发风险;预防性治疗主要用于复发性疾病.
结论:
- 像IL-6受体和新生儿Fc受体抑制等新兴疗法显示出MOGAD治疗的前景.
- 标准化标准的开发和正在进行的试验正在推动MOGAD患者护理.
更多相关视频
10:47Simple and Efficient Production and Purification of Mouse Myelin Oligodendrocyte Glycoprotein for Experimental Autoimmune Encephalomyelitis Studies
Published on: October 27, 2016
08:03Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice
Published on: April 15, 2014
相关概念视频
Pharmacodynamics: Overview and Principles
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Alzheimer's Disease: Treatment
Treatment Strategies for Psychological Disorders
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Treatment Resistant Cancers
